Korro Bio News and Activities
Presence
Korro Bio is a biotechnology company that develops RNA editing medicines for genetic diseases. Its therapies and research programs serve patients, healthcare providers, and pharmaceutical partners.
Korro Bio products and services overview:
- RNA editing therapies
- Genetic disease treatments
- Liver disease therapies
- Drug discovery
- Research partnerships
Revenue: ~$0 million
Employees: 130
Headquarters: Cambridge, United States (USA)
Korro Bio is one of the...
Korro Bio is a company listed under the stock ticker KRRO (US).
Executives
View the org chart displaying its 16 main executives
Most searched biographies at Korro Bio
- Ram Aiyar, Chief Executive Officer, Director and Interim Chief Fin...
- Nessan Bermingham, Co-Founder and Executive Chairman of the Board
- Rachel Meyers, Director
Create your alert
to follow the executive moves at Korro Bio.
Biotechnology
Korro Bio has 2,430 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).
Popular M&A news in Biotechnology
- Eli Lilly has announced the acquisition of AtaiBeckley (posted on July 17 2026).
- GSK has acquired Nuvalent (posted on July 17 2026).
- Clearside Biomedical has gone out of its bankruptcy protection (posted on July 15 2026).
Popular contacts in Biotechnology
News
Press releases by Korro Bio
- Korro Bio Announces Collaboration with Novo Nordisk to Develop Two Therapeutic Candidates | Korro Bio, Inc.
- Korro to Participate in Upcoming Investor Conferences | Korro Bio, Inc.
- Korro Announces Addition of Industry Veteran Katharine Knobil to and Resignation of David Lucchino From Its Board of Directors | Korro Bio, Inc.
- Korro to Participate in Upcoming September Investor and Scientific Conferences | Korro Bio, Inc.
- Korro Reports Second Quarter 2024 Financial Results and Provides Business Updates | Korro Bio, Inc.
- Korro to Participate in Upcoming June Investor and Scientific Conferences | Korro Bio, Inc.
- Korro Joins the Russell 2000®, Russell 3000®, and Russell Microcap® Indexes | Korro Bio, Inc.
- Korro Presents Additional Preclinical Data for KRRO-110 at the American Thoracic Society 2024 International Conference | Korro Bio, Inc.
- Korro Joins the Russell 2000®, Russell 3000®, and Russell Microcap® Indexes – Korro BioBack ButtonSearch IconFilter Icon
- Korro to Participate in Upcoming June Investor and Scientific Conferences – Korro BioBack ButtonSearch IconFilter Icon
- View more press releases Close
Social media about Korro Bio
- Korro Bio on Wikipedia, Google News & Yahoo Finance
- Korro Bio on LinkedIn, X (Twitter) & YouTube
